Login / Signup

Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.

Jung Won LeeNa Young KimRyoung Hee NamSun Min LeeChoi Soo InJung Mogg KimDong Ho Lee
Published in: Journal of gastroenterology and hepatology (2019)
For cases with metronidazole resistance at MIC > 32 μg/mL, rescue therapy other than bismuth-containing quadruple therapy is needed.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • risk factors
  • stem cells
  • mesenchymal stem cells
  • oxide nanoparticles